Welcome to the State of California 

MDL logo

Test Order

Mycobacterium TB Complex Identification and Pyrazinamide Susceptibility Testing

Pre-Approval Required

None

Supplemental Information or Form

None

Performed on Specimens from

Human patients

Acceptable Sample/ Specimen Type for Testing

Pure culture

Minimum Volume Required

1 ml liquid with visible bimass or solid medium culture less than 6 week old

Storage & Preservation of Specimen Prior to Shipping

None

Transport Medium

None

Specimen Labeling

None

Shipping Instructions which Include Specimen Handling Requirements

None

Test Methodology

TB complex identification may use high performance liquid chromatography to identify BCG vaccine strains, or a combination of growth characteristics and biochemicals to identify M. bovis.  Pyrazinamide susceptibility testing is performed using Mycobacterial Growth Indicator Tube (MGIT) broth.

Turnaround Time

None

Interferences & Limitations

None

Additional Information

Cultures of M. bovis are resistant to pyrazinamide (PZA).  Members of the TB complex which are resistant only to PZA are  M. bovis or possibly a mono-resistant M.tb.

MDL Points of Contact

Mycobacterial Diseases Section (510) 412-3929
Email: grace.lin@cdph.ca.gov

 

 
 
Last modified on: 1/8/2015 8:37 AM